Go directly to content Go directly to font size and contrast

Project Details

Institution

Print View

Universitätsklinikum Tübingen
Abteilung für Peptid-basierte Immuntherapie

Address Otfried-Müller-Straße 10
72076 Tübingen
Deutschland

GERiT This institution in GERiT

72076 Tübingen

Projects

Research Grants
- Current projects
  - Medical Innovation through Interdisciplinarity Clinician Scientist (MINT-CS) program
    (Applicant Lengerke, Claudia )
  - The soluble HLA immunopeptidome as active modulator and biomarker for T cell immunity in SARS-CoV-2 infection and COVID-19
    (Applicant Walz, Juliane )
- Completed projects
  - HLA ligandome analysis of Multiple Myeloma - Novel myeloma-associated antigens for peptide-based immunotherapy
    (Applicant Walz, Juliane )
Clinical Trials
- Current projects
  - iVAC-HNSCC01: Two-arm, placebo-controlled, double-blinded, randomized Phase II study to evaluate efficacy and safety of personalized multi-peptide vaccination in combination with Pembrolizumab in patients with unresectable recurrent, or metastatic head and neck squamous cell carcinoma
    (Applicant Walz, Juliane )
Clusters of Excellence (ExStra)
- Current projects
  - EXC 2124: Controlling Microbes to Fight Infections (CMFI)
    (Spokespersons Brötz-Oesterhelt, Heike ; Ley, Ph.D., Ruth ; Peschel, Andreas )
  - EXC 2180: Image-guided and Functionally Instructed Tumor Therapies (iFIT)
    (Spokespersons Pichler, Bernd ; Walz, Juliane ; Zender, Lars )

© 2026 DFG Disclaimer / Copyright / Privacy Policy